Dr. Chow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 The City Drive South
Building 63, Room 412, ZOT 4061
Orange, CA 92868Phone+1 714-456-5153Fax+1 714-456-2242- Is this information wrong?
Education & Training
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1986 - 1990- Cedars-Sinai Medical CenterInternship, Internal Medicine, 1986 - 1987
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1986
Certifications & Licensure
CA State Medical License 1987 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Top Doctors:LA Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Clinical Trials
- Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Start of enrollment: 2011 Apr 01
- Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung Start of enrollment: 2013 Apr 01
- SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma.Jeremy P Harris, Jino Park, Eric Ku, Steven Seyedin, Russell Stitzlein, Amanda Goldin, Wen-Pin Chen, Christine McLaren, Allen M Chen, Warren Chow> ;Cancer Control. 2024 Mar 7
- Phosphaturic mesenchymal tumor withliver metastases: a case report and literature review.Sami Dwabe, Warren Chow> ;Therapeutic Advances in Medical Oncology. 2024 Jan 1
- The Correlation Between Lymphocyte Nadir and Radiation Therapy for Soft Tissue Sarcoma: Defining Key Dosimetric Parameters and Outlining Clinical Significance.Ku, E., Harada, G., Chiao, E., Rao, P., Hosseinian, S., Maxim, P., Limoli, C., Seyedin, S., Healy, E., Chow, W., Stitzlein, R., Harris, J.> ;Advances in Radiation Oncology. 2024 Jan 1
- Join now to see all
Press Mentions
Extended Chemo Extends Life for Children with Rare CancerJune 3rd, 2018- Random Mutations May Be Leading Cause of OncogenesisApril 11th, 2017
Random Mutations May Be Leading Cause of OncogenesisApril 11th, 2017- Join now to see all
Hospital Affiliations
UCI HealthOrange, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
